Elizabeth Burke
About Elizabeth Burke
Elizabeth Burke is a scientist specializing in the use of zebrafish disease models to study unknown neurological and developmental conditions. She has a Ph.D. in Molecular Medicine and has worked at the National Institutes of Health since 2011.
Work at National Institutes of Health
Elizabeth Burke has been a scientist at the Undiagnosed Diseases Program at the National Institutes of Health (NIH) since 2015. Prior to this role, she served as a Postdoctoral Fellow in the same program from 2011 to 2015. Her work at NIH focuses on utilizing zebrafish disease models to investigate the molecular basis of unknown neurological and developmental conditions. Additionally, she has experience working at the National Human Genome Research Institute (NHGRI) as a Post-baccalaureate Intramural Research Training Award Fellow from 2004 to 2005.
Education and Expertise
Elizabeth Burke earned her Bachelor of Arts (B.A.) in Biology from Carleton College, where she studied from 2000 to 2004. She continued her education at Wake Forest University School of Medicine, obtaining a Doctor of Philosophy (Ph.D.) in Molecular Medicine and Translational Science from 2005 to 2011. Her academic background provides a strong foundation for her research in molecular biology and genetics, particularly in the context of neurological and developmental disorders.
Research Focus and Methodology
In her research, Elizabeth Burke employs zebrafish disease models to explore the molecular mechanisms underlying various unknown neurological and developmental conditions. This approach allows for the investigation of complex biological processes in a model organism, facilitating the understanding of genetic factors that contribute to these conditions. Her work contributes to the broader field of genomic research and aims to uncover insights that may lead to improved diagnostic and therapeutic strategies.
Public Engagement in Science Communication
Elizabeth Burke actively translates complex scientific publications into accessible information for the general public. This effort aims to enhance understanding of advances in genomic research, making scientific knowledge more approachable. By bridging the gap between scientific research and public comprehension, she contributes to the dissemination of important information related to health and disease.